| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| M B Sättler, D Merkler, K Maier, C Stadelmann, H Ehrenreich, M Bähr, R Die. Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Cell death and differentiation. vol 11 Suppl 2. 2005-06-09. PMID:15459752. |
in the present study, we show that, in rats suffering from myelin oligodendrocyte glycoprotein (mog)-induced optic neuritis, systemic application of erythropoietin (epo) significantly increased survival and function of retinal ganglion cells (rgcs), the neurons that form the axons of the optic nerve. |
2005-06-09 |
2023-08-12 |
rat |
| Petra Kleindienst, Carsten Wiethe, Manfred B Lutz, Thomas Brocke. Simultaneous induction of CD4 T cell tolerance and CD8 T cell immunity by semimature dendritic cells. Journal of immunology (Baltimore, Md. : 1950). vol 174. issue 7. 2005-06-07. PMID:15778350. |
pretreatment of c57bl/6 mice with encephalitogenic myelin oligodendrocyte glycoprotein (mog)(35-55) peptide-loaded semimature dc protected from mog-induced autoimmune encephalomyelitis. |
2005-06-07 |
2023-08-12 |
mouse |
| Annette van der Goes, Wiebe Boorsma, Karin Hoekstra, Lisette Montagne, Corline J A de Groot, Christine D Dijkstr. Determination of the sequential degradation of myelin proteins by macrophages. Journal of neuroimmunology. vol 161. issue 1-2. 2005-05-27. PMID:15748939. |
demonstration of different myelin proteins (myelin basic protein [mbp], proteolipid protein [plp] and myelin oligodendrocyte glycoprotein [mog]) is used as a tool to determine the stage of ms lesions in autopsy tissue. |
2005-05-27 |
2023-08-12 |
human |
| Saad Muhallab, Ingrid Dahlman, Erik Wallströ. Disparate MHC class II haplotypes in myelin oligodendrocyte glycoprotein- and myelin basic protein-induced experimental autoimmune encephalomyelitis. Journal of neuroimmunology. vol 161. issue 1-2. 2005-05-27. PMID:15748954. |
immunization with recombinant myelin oligodendrocyte glycoprotein (a.a.1-125; mog)/ifa induced eae in strains expressing the mhc class ii allele rt1.b(n), whereas strains expressing the rt1.b(l) were resistant. |
2005-05-27 |
2023-08-12 |
rat |
| Muriel B Sättler, Ricarda Diem, Doron Merkler, Iris Demmer, Ina Boger, Christine Stadelmann, Mathias Bäh. Simvastatin treatment does not protect retinal ganglion cells from degeneration in a rat model of autoimmune optic neuritis. Experimental neurology. vol 193. issue 1. 2005-05-24. PMID:15817275. |
we demonstrated previously that myelin oligodendrocyte glycoprotein (mog)-induced experimental autoimmune encephalomyelitis in rats provokes severe axonal and neuronal injury even before clinical manifestation of the disease. |
2005-05-24 |
2023-08-12 |
rat |
| Dusanka S Skundric, Rujuan Dai, Vaagn L Zakarian, Denise Bessert, Robert P Skoff, William W Cruikshank, Zlatan Kurjakovi. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE. Journal of neuroscience research. vol 79. issue 5. 2005-05-09. PMID:15682385. |
we reported that (b6xsjl) f1 (h-2b/s) mice with severe relapsing-remitting disease had extensive infiltration by cd4+ t cells compared to that in c57bl/6 (b6) (h-2b) mice, which developed mild low-relapsing disease in response to myelin oligodendrocyte peptide 35-55 (mog(35-55)). |
2005-05-09 |
2023-08-12 |
mouse |
| G Zai, N King, K Wigg, J Couto, G W H Wong, W G Honer, C L Barr, J L Kenned. Genetic study of the myelin oligodendrocyte glycoprotein (MOG) gene in schizophrenia. Genes, brain, and behavior. vol 4. issue 1. 2005-04-29. PMID:15660663. |
genetic study of the myelin oligodendrocyte glycoprotein (mog) gene in schizophrenia. |
2005-04-29 |
2023-08-12 |
human |
| G Zai, N King, K Wigg, J Couto, G W H Wong, W G Honer, C L Barr, J L Kenned. Genetic study of the myelin oligodendrocyte glycoprotein (MOG) gene in schizophrenia. Genes, brain, and behavior. vol 4. issue 1. 2005-04-29. PMID:15660663. |
the myelin oligodendrocyte glycoprotein (mog) gene, which is located close to the hla region, is considered a candidate for scz due to its association with white matter abnormalities and its importance in mediating the complement cascade. |
2005-04-29 |
2023-08-12 |
human |
| Ikuo Tsunoda, Li-Qing Kuang, Isaac Z M Igenge, Robert S Fujinam. Converting relapsing remitting to secondary progressive experimental allergic encephalomyelitis (EAE) by ultraviolet B irradiation. Journal of neuroimmunology. vol 160. issue 1-2. 2005-04-28. PMID:15710465. |
we induced experimental allergic encephalomyelitis (eae) in sjl/j mice, an animal model for multiple sclerosis (ms), using myelin oligodendrocyte glycoprotein (mog)(92-106) peptide, following ultraviolet (uv) irradiation. |
2005-04-28 |
2023-08-12 |
mouse |
| I Kurkowska-Jastrzebska, E Bałkowiec-Iskra, I Joniec, T Litwin, A Członkowski, A Członkowsk. Immunization with myelin oligodendrocyte glycoprotein and complete Freund adjuvant partially protects dopaminergic neurons from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced damage in mouse model of Parkinson's disease. Neuroscience. vol 131. issue 1. 2005-04-25. PMID:15680707. |
c57bl mice were immunized with either myelin oligodendrocyte glycoprotein (mog) 35-55 combined with complete freund adjuvant (cfa), or cfa alone. |
2005-04-25 |
2023-08-12 |
mouse |
| Cecilia B Marta, Michael B Montano, Christopher M Taylor, Ava L Taylor, Rashmi Bansal, Steven E Pfeiffe. Signaling cascades activated upon antibody cross-linking of myelin oligodendrocyte glycoprotein: potential implications for multiple sclerosis. The Journal of biological chemistry. vol 280. issue 10. 2005-04-19. PMID:15634682. |
in particular, antibodies to myelin oligodendrocyte glycoprotein (mog) are elevated in multiple sclerosis patients, and they have been implicated as mediators of demyelination. |
2005-04-19 |
2023-08-12 |
Not clear |
| Andreas Bitsch, Alexander Dressel, Kathrin Meier, Timon Bogumil, Florian Deisenhammer, Hayrettin Tumani, Bernd Kitze, Sigrid Poser, Frank Webe. Autoantibody synthesis in primary progressive multiple sclerosis patients treated with interferon beta-1b. Journal of neurology. vol 251. issue 12. 2005-03-29. PMID:15645350. |
we conducted an open-labeled clinical trial of interferon beta-1b (ifnb) treatment in 20 patients with primary progressive multiple sclerosis (ppms) and longitudinally monitored autoantibodies against double-stranded dna (dsdna), thyroid peroxidase (tpo),myelin basic protein (mbp), myelin oligodendrocyte glycoprotein (mog), synapsin and s-100b. |
2005-03-29 |
2023-08-12 |
Not clear |
| Shinya Hirata, Satoru Senju, Hidetake Matsuyoshi, Daiki Fukuma, Yasushi Uemura, Yasuharu Nishimur. Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand. Journal of immunology (Baltimore, Md. : 1950). vol 174. issue 4. 2005-03-29. PMID:15699115. |
in the current study, we tested a strategy to prevent eae by pretreatment of mice with genetically modified dendritic cells (dc) presenting myelin oligodendrocyte glycoprotein (mog) peptide in the context of mhc class ii molecules and simultaneously expressing trail or programmed death-1 ligand (pd-l1). |
2005-03-29 |
2023-08-12 |
mouse |
| Cécile Besson Duvanel, Florianne Monnet-Tschudi, Olivier Braissant, Jean-Marie Matthieu, Paul Honegge. Tumor necrosis factor-alpha and alphaB-crystallin up-regulation during antibody-mediated demyelination in vitro: a putative protective mechanism in oligodendrocytes. Journal of neuroscience research. vol 78. issue 5. 2005-02-28. PMID:15478179. |
differentiated aggregate cultures of rat telencephalon were subjected to demyelination by exposure to antibodies against myelin oligodendrocyte glycoprotein (mog) and complement. |
2005-02-28 |
2023-08-12 |
rat |
| Mandy L Ford, Brian D Evavol. Specificity, magnitude, and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis. European journal of immunology. vol 35. issue 1. 2005-02-23. PMID:15593305. |
here, we provide evidence for the existence of mouse cd8(+) t cells that are specific for an epitope of the myelin oligodendrocyte glycoprotein (mog). |
2005-02-23 |
2023-08-12 |
mouse |
| Ricarda Diem, Muriel B Sättler, Doron Merkler, Iris Demmer, Katharina Maier, Christine Stadelmann, Hannelore Ehrenreich, Mathias Bäh. Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis. Brain : a journal of neurology. vol 128. issue Pt 2. 2005-02-22. PMID:15601662. |
after immunization with myelin oligodendrocyte glycoprotein (mog), animals were randomly assigned to six treatment groups receiving different combinations of erythropoietin and methylprednisolone, or respective monotherapies. |
2005-02-22 |
2023-08-12 |
rat |
| Gwyneth Zai, Yarema B Bezchlibnyk, Margaret A Richter, Paul Arnold, Eliza Burroughs, Cathy L Barr, James L Kenned. Myelin oligodendrocyte glycoprotein (MOG) gene is associated with obsessive-compulsive disorder. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 129B. issue 1. 2005-02-16. PMID:15274043. |
myelin oligodendrocyte glycoprotein (mog) gene is associated with obsessive-compulsive disorder. |
2005-02-16 |
2023-08-12 |
Not clear |
| Gwyneth Zai, Yarema B Bezchlibnyk, Margaret A Richter, Paul Arnold, Eliza Burroughs, Cathy L Barr, James L Kenned. Myelin oligodendrocyte glycoprotein (MOG) gene is associated with obsessive-compulsive disorder. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 129B. issue 1. 2005-02-16. PMID:15274043. |
genes involved in immune response therefore represent possible candidate genes for ocd, including the myelin oligodendrocyte glycoprotein (mog) gene, which plays an important role in mediating the complement cascade in the immune system. |
2005-02-16 |
2023-08-12 |
Not clear |
| Thomas P Finn, Richard E Jones, Cathleen Rich, Rony Dahan, Jason Link, Chella S David, Yuan K Chou, Halina Offner, Arthur A Vandenbar. HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes. Journal of neuroscience research. vol 78. issue 1. 2005-02-07. PMID:15372502. |
we found that tg drb1*1502 mice had moderate to strong t-cell responses to several myelin peptides with favorable drb1*1501 binding motifs, notably myelin oligodendrocyte glycoprotein (mog)-35-55 (which was also encephalitogenic), proteolipid protein (plp)-95-116, and mog-194-208, as well as other plp and mog peptides. |
2005-02-07 |
2023-08-12 |
mouse |
| Catherine Uyttenhove, Berenice Arendse, Vincent Stroobant, Frank Brombacher, Jacques Van Snic. Development of an anti-IL-12 p40 auto-vaccine: protection in experimental autoimmune encephalomyelitis at the expense of increased sensitivity to infection. European journal of immunology. vol 34. issue 12. 2005-02-03. PMID:15549728. |
myelin oligodendrocyte glycoprotein (mog)-induced disease in c57bl/6 mice was also significantly inhibited. |
2005-02-03 |
2023-08-12 |
mouse |